Powered by UGP Software, Omicia is Finalist for 100,000 Genomes Project

California-based Omicia, Inc. has been selected by Genomics England as a top ten finalist for the 100,000 Genomes Project. Omicia's software platform, Opal, provides user-friendly researcher and clinician support for genome interpretation. Opal is powered by VAAST and Phevor algorithms, built by Utah Genome Project investigators.

The 100,000 Genomes Project  is an initiative to sequence UK-based participants to create a dataset of anonymous whole genome sequences matched with clinical data at massive scale, and make that data available for research and development. Seen as a significant step toward personalized medicine, the project is predicted to be completed in 2017.

Omicia was selected as a project finalist based on Opal's ability to assess 25 sets of genomic samples from people with rare diseases or cancer. Omicia, along with Congenica, Diploid, Nantomics, Genomics Ltd, Illumina, Qiagen, Lockheed Martin, Nextcode, and Personalis will move to the next stage of evaluation as potential service providers.  

Next-Generation Genome Interpretation And Reporting Software